Chargement en cours...

IL-33 in Tumor Immunity: Nothing to Sneeze At

Although immunotherapy has been at the forefront of cancer therapy for the last several years, better clinical responses are still desired. Interleukin-33 is perhaps one of the most overlooked antitumor cytokines. Its ability to promote type 1 immune responses, winch control tumor growth in preclini...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Crit Rev Immunol
Auteurs principaux: Dominguez, Donye, Zhang, Yi, Zhang, Bin
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7087446/
https://ncbi.nlm.nih.gov/pubmed/31002600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1615/CritRevImmunol.2018026335
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!